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Abstract
Background: Human cytomegalovirus (HCMV) is an important pathogen of viral pneumonia in children. The
diagnosis of acute HCMV infection is complicated and difficult.
Methods: Clinical and laboratory data of 6063 hospitalized children with respiratory infection and 509 with
respiratory virus infection alone were retrospectively analyzed. Urine and respiratory specimens of 186 hospitalized
children with pneumonia were also prospectively collected. Real-time polymerase chain reaction (PCR) and a
chemiluminescent assay were used to detect HCMV DNA copy number, the pp65 gene, and HCMV IgM.
Results: The patients with respiratory virus infection alone and those with pulmonary HCMV infection (n = 422)
were mostly children aged <6 months old (82.91%, 422/509). The accuracy of urine HCMV DNA (82.32%) was higher
than that of HCMV IgM (67.78%), indicating that PCR of urine samples is suitable for determining pediatric acute
pulmonary HCMV infection. There was no significant difference in detecting HCMV DNA or the pp65 gene between
urinary and respiratory specimens (P > 0.05) in 186 pediatric pneumonia cases. The accuracy of the pp65 gene
measured in urine for determining acute pulmonary HCMV infection was the highest (93.01%).
Conclusions: Our study shows a novel method for investigating acute pulmonary HCMV infection in children by
using real-time PCR and non-invasive samples. This study also highlights the superiority and potential use of the
pp65 gene as an important target for the diagnosis of acute pulmonary HCMV infection.
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Background
Pneumonia is a serious and frequent cause of hospital
admission in childhood. Approximately 2 million chil-
dren die from pneumonia annually, and 90% of these
deaths occur in developing countries [1,2]. According to
the pathogen, pneumonia is divided into viral pneumonia
and bacterial pneumonia. Viral pneumonia is different
from that caused by bacteria, and appears as a disease
associated with fever, headache, and an increased number
of white blood cells (WBCs). Viral pneumonia is fre-
quently caused by respiratory syncytial virus (RSV),
influenza virus, human cytomegalovirus (HCMV), and
parainfluenza virus. HCMV belongs to the Herpesviridae
family, Betaherpesvirinae subfamily, and Cytomegalovirus
genus, and it causes pneumonia, hepatitis, and mono-
nucleosis [3]. HCMV pneumonia is complicated and hard
to diagnose because its symptoms are similar to other viral
pneumonias. HCMV leads to pneumonia when it becomes
reactive and is located in the lungs. The symptoms and
signs of children with HCMV pneumonia are not specific
enough for diagnosis in the clinical setting.
Several laboratory tests are applied to help with diagnosis
of HCMV infection, including viral isolation and culture,
serology, CMV inclusion body detection, and molecular-
based assays. The gold standard for diagnosis of HCMV
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infection is viral isolation and culture, but the requirements
for this procedure are too great for popular use in clinical
practice [4,5]. Viral isolation and culture are relatively in-
tensive and time consuming. In most clinical laboratories,
serological assays and polymerase chain reaction (PCR) are
the main methods for detecting HCMV infection. Sero-
logical assays based on IgM and IgG detection provide a
method for identifying HCMV infection, but IgM results
are not reliable in certain circumstances. One of the issues
is that there is no sufficient circulating antibody in child
patients [6]. Moreover, the IgG serological assay is not able
to show acute infection. Although the presence of HCMV
inclusion bodies indicates active viral replication, the posi-
tive percentage of this method is too low to help determine
HCMV infection [7]. Real-time PCR has been developed to
detect HCMV because of its time-saving feature, and high
sensitivity and specificity [8]. However, there are few re-
ports on the relationship between real-time PCR results
and clinical diagnosis for HCMV related to pneumonia
in the pediatric population. Although the best sample
for detecting HCMV pneumonia by real-time PCR is a
respiratory specimen [sputum or bronchoalveolar lavage
fluid (BALF)], collecting serological specimens by an in-
vasive procedure and respiratory specimens is difficult
for children, especially those younger than 1 year old.
Measuring pulmonary HCMV infection by using nonin-
vasive samples (e.g., urine) would be helpful.
A family of proteins that are localized to the HCMV
tegument are called “tegument proteins” [9]. Among them,
pp65 is the major tegument protein responsible for modu-
lating the host cell immune response in infection [10]. The
protein pp65 is dispensable for replication and essential for
the formation of dense bodies. When HCMV invades host
cells, pp65 is recognized by the host immune system to
protect infected cells [11,12]. Expression of the pp65 gene
enhances HCMV reactivation. Antigenemia for pp65 anti-
gen is widely used to detect pp65 expression [13-15]. How-
ever, the immunofluorescent assay is objective, and its
sensitivity and specificity is lower than that of real-time
PCR. In clinical practice, an effective and fast assay needs
to be established to identify HCMV infection in the latent
or active stage.
Although the clinical and molecular characteristics of
HCMV infection have been reported, few of these char-
acteristics are known in the pediatric population with
viral pneumonia alone. This study aimed to establish a
new standard for detecting acute HCMV infection, be-
cause diagnosing pneumonia with HCMV infection is still
difficult. In the current study, we found that real-time
PCR is more specific and sensitive than a chemilumines-
cent assay for HCMV infection in 509 pediatric hospital-
ized children with pneumonia. Results from urine samples
appear to be consistent with those from sputum or BALF
for pneumonia with acute HCMV infection. Moreover,




We conducted a retrospective and consecutive study in
the Children’s Hospital of Chongqing Medical University,
China, from April 2009 to February 2013. For the retro-
spective study, 6063 male and female children between
1 day and 6 years old were hospitalized for respiratory in-
fection, and 2201 children had pneumonia. There was a
total of 509 children conforming to the inclusion criteria
(see “Interpretation” section below), and they were included
in the retrospective study. From February 2013 to August
2013, blood, urine, and respiratory specimens (sputum or
BALF) of 500 children with pneumonia were collected,
and 186 of them conformed to the inclusion criteria for
the prospective study (see “Interpretation” section below).
The study was approved by the Ethics Committee of the
Children’s Hospital of Chongqing Medical University and
the reference number was chcmu-20090005. Written in-
formed consent was obtained from the parents or legal
guardians of the patients.
Data collection
Clinical and laboratory data were collected from the
medical records of the patients. The clinical data included
sex, age, season, duration of illness, symptoms, signs, and
X-ray image information. Laboratory data included periph-
eral leukocytes, neutrophil proportion, lymphocyte pro-
portion, monocyte proportion, eosinophil proportion, copy
number of HCMV DNA, and specific IgM antibody titer
for HCMV.
Interpretation
The inclusion criteria for the retrospective study were as
follows. (1) Patients were included who were confirmed
as having pneumonia with typical symptoms, such as
cough, wheezing, sore throat and fever, as confirmed by
X-ray [16]; (2) Patients were included who had a normal
immune system [including WBC count, absolute lympho-
cyte count, and proportion of individual subpopulations
of lymphocytes, such as T(CD3+), Th(CD4+), and Ts
(CD8+)], as detected by flow cytometry (BD Multitest
IMK Kit, USA)] [17] (data not shown); (3) Patients were
included who were infected by virus alone. Sputum or
blood culture was used to show no infection by bacteria,
fungus, or Mycoplasma pneumoniae (MP) (Additional
file 1: Table S1). A chemiluminescent assay (Abbott Ireland
Diagnostics Division, Sligo, Ireland) and respiratory virus
antigen detection kit (Diagnostic Hybrids Inc., OH, USA)
were used to screen for respiratory virus infection
(Additional file 1: Table S2). Chlamydia pneumoniae (CP)
was detected by a commercial quantitative diagnostic kit
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with PCR fluorescence probing (Da’an Gene Co., Ltd.,
Guangzhou, China); (4) There was no evidence to show
that the patients suffered from severe concomitant diseases
and nosocomial infections; (5) The patients did not receive
any antibiotics or anti-viral drugs 48 h before diagnosis; (6)
Patients could be included under the condition that they
only had pulmonary HCMV infection, but did not have
cytomegalovirus hepatitis or encephalitis. The inclusion
criteria for the prospective study were the same as those
for the retrospective study.
The guidelines for diagnosis of HCMV pneumonia were
based on Paya et al.’s report [18]. Briefly, the patients had
typical symptoms of pneumonia. X-rays showed evidence
of diffuse lesions. Sputum and blood culture were used to
prove that patients were free of bacterial, fungal, and MP
infections. The results of PCR, chemiluminescent assay,
and detection of virus antigen were used to show that
there was no CP or other viral infections. HCMV IgM or
HCMV DNA was positive and HCMV IgG was negative.
Moreover, antibiotic treatment was invalid, but ganciclovir
treatment was valid. Acute HCMV infection in our study
was defined as follows: those who were free of bacterial,
MP, CP, and fungal infections (shown by sputum and blood
culture, and PCR), as well as infection from other viruses
(shown by chemiluminescent assay or positive respiratory
virus antigen detection); positive HCMV IgM or positive
HCMV DNA and negative HCMV IgG; and those re-
ceiving invalid antibiotic treatment, but valid ganciclovir
treatment. Latent HCMV infection was defined as fol-
lows: those who were HCMV IgM-negative, HCMV
IgG-positive, and with other viral infections (shown by
chemiluminescent assay or positive respiratory virus anti-
gen detection); those who were free of bacterial, MP, CP,
and fungal infection (shown by sputum and blood culture,
and PCR); and improvement without receiving ganciclovir.
According to the presence of HCMV infection, the pa-
tients were classified as the HCMV-infection group, bi/
tri-virus-infection group (multiple viral infections), and
the non-HCMV-infection group.
Real-time PCR for HCMV DNA
Detection of the copy number of HCMV DNA was per-
formed by using the HCMV DNA quantitative diagnostic
kit with PCR fluorescence probing (Da’an Gene Co., Ltd.),
as previously reported [19]. This technique is based on
TaqMan PCR technology, and the target sequence is in a
highly conserved fragment of the HCMV genome (strain
AD169).
Briefly, 1 ml of urine specimen was centrifuged at
13,000 × g. Urine supernatant was discarded and the pellet
was collected and mixed with 50 μl of DNA extraction so-
lution. The supernatant was then collected. Respiratory
specimens were liquefied with 4% NaOH, and then centri-
fuged at top speed. The pellet was collected and washed.
The pellet was then mixed with 50 μl of DNA extraction
solution, and the supernatant was collected.
A volume of 2 μl of the supernatant and 43 μl of PCR
mix (Da’an Gene Co., Ltd.) were used to perform real-
time PCR, using the Applied Biosystems 7500 real-time
PCR system (Applied Biosystems, CA, USA) as follows:
93°C for 2 min, 10 cycles of 93°C for 45 s, and 55°C for
60s, followed by 30 cycles of 93°C for 30 s and 55°C for
45 s. For each assay, we used positive viral load standards
(104, 105, 106, and 107 copies/mL), plasmid target sequence
(500 copies/ml) as a positive control, ddH2O as a blank
control, and plasmid without target sequence as a negative
quality control. HCMV DNA >500 copies per ml of speci-
men was regarded as positive.
Chemiluminescent microparticle immunoassay for HCMV
IgM antibody
Peripheral blood specimens were used for serological tests.
HCMV-specific antibody was detected using a commercial
kit (Architect CMV IgM 6C16, Abbott, Sligo, Ireland) ac-
cording to the manufacturer’s instructions [20]. The Archi-
tect CMV IgM assay is a two-step immunoassay for the
qualitative detection and semi-quantitative determination
of IgM antibodies to HCMV in human serum and plasma.
The results were measured as relative light units. If the
chemiluminescent signal in the specimen was equal to or
greater than 1.00, anti-CMV IgM was considered positive.
If the signal in the specimen was lower than 0.85, anti-
CMV IgM was considered negative. If the results were un-
certain, we examined a second sample within a reasonable
period of time (e.g., 2 weeks) to confirm the results. In
addition, RSV, adenovirus, and Epstein-Barr virus were
tested by chemiluminescent assay kits from Abbott.
Real-time PCR for the pp65 gene in clinical specimens
A total of 186 suspected HCMV-positive cases were in-
cluded. Urinary and respiratory specimens of these pa-
tients were collected and DNA was extracted. The DNA
purification process of urinary and respiratory specimens
was the same as that mentioned above (“Real-time PCR
for HCMV DNA” section). A volume of 2 μl of the
resulting supernatant and 18 μl of PCR mix were used
to perform real-time PCR. The PCR mixture contained
8 μl 2.5 × Real-MasterMix, 1 μl probe enhancer (Tiangen
Biotech, Beijing, China), 1 μl internal TaqMan probe
(20 μmol/L), 4 μl nuclease-free water, and 2 μl forward
and reverse primers (10 μmol/L) each.
The sequence of the pp65 gene was from Genebank
(AY301013). The forward primer was 5′-CCC TCC GGC
AAG CTC TTT-3′ and the reverse primer was 5′-CAG
GTC CTC TTC CAC GTC AGA-3′. The internal TaqMan
probe 5′-TGC ACG TCA CGC TGG-3′ was labeled at the
5′ end with 6-carboxy-fluorescein as the reporter and at
the 3′ end with minor groove binding as the quencher
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[21]. The primers and probe were synthetized by Invitro-
gen (Life Technologies Corporation, Shanghai, China).
Purified genomic DNA from the HCMV-positive specimen
was the template and was amplified by PCR. The PCR
product was sequenced to confirm whether the sequence
was the exact target sequence, and was then ligated to
the pBackZero-T vector (TaKaRa, Dalian, China); this was
called the pp65-plasmid. The pp65-plasmid concentrations
were measured by ultraviolet spectrophotometry to calcu-
late the copy number of the plasmid, and to further obtain
viral load standards (104, 105, 106, and 107 copies/mL) and
the positive quality control (103 copies/ml) for real-time
PCR. Moreover, ddH2O as a blank control, and plasmid
without a target sequence as a negative quality control,
were prepared and used for each assay. PCR was per-
formed using the 7500 real-time PCR system (Applied Bio-
systems, CA, USA) under the following conditions: one
cycle of 50°C for 2 min and 95°C for 10 min, followed by
40 cycles of 95°C for 15 s and 55°C for 45 s. All of the stan-
dards, controls, and samples were run in triplicate.
Statistical analysis
Quantitative data are expressed as mean ± SD if they
followed a normal distribution, or are described as medians
and interquartile ranges (25th–75th). Categorical data are
expressed as frequencies and percentages. The relation-
ships between acute and chronic pneumonia, pathological
classification, sex, age, and HCMV infection were evalu-
ated by logistic regression analysis. Differences in clinical
symptoms of categorical variables were determined by the
chi-square test. Differences in WBCs, duration of illness,
and vital signs of categorical variables were determined
using analysis of variance. Paired proportions of discordant
serological and PCR results in the different groups were
compared with the clinical diagnosis. Paired PCR results of
different specimens were tested by McNemar’s test. The
receiver operating characteristic curve was used to predict
the pp65 gene as a marker for identifying acute HCMV in-
fection or latent HCMV infection in children with pneu-
monia. Data were analyzed by SAS 9.13 (SAS Institute,
Cary, NC, USA).
Results
Patients and general characteristics
A total of 6063 children with respiratory infection were
investigated and 509 children were included in the retro-
spective study according to the inclusion criteria. The
general characteristics of children in our retrospective study
are shown in Additional file 1: Table S3.
The age of children with respiratory infection ranged
from 1 day to 6 years old. The ratio of boys to girls was
2.20:1. The median duration of illness was 7.0 days. Ac-
cording to Hu et al.’s report [22], the odds ratio of HCMV
pneumonia is highest in children younger than 6 months
old. Therefore, the children in our retrospective study
were grouped into <6 months and ≥6 months. There were
no significant differences in the general characteristics of
children with respiratory infection, including the odds ra-
tio of HCMV infection in different sex groups, the per-
centage of patients with positive clinical manifestations,
the duration of different types of pneumonia, and the inci-
dence rate of severe pneumonia among different groups
(Additional file 1: Tables S4–S6).
Classification of viral pneumonia in patients with
HCMV infection
Because viral pneumonia can be classified based on the
duration of illness or anatomy, we observed the differ-
ences in the duration of illness and anatomy between pa-
tients with or without HCMV infection. There were 507
cases of acute viral pneumonia or unresolved viral pneu-
monia, and only two cases of chronic viral pneumonia.
Among the cases of acute viral pneumonia, there were
130 cases of HCMV infection and 116 cases of multiple
viral infections. For 42 unresolved cases of pneumonia,
there were 15 cases of HCMV infection and 17 cases of
multiple viral infection (Table 1). Cases of chronic pneu-
monia were too few to compare, and were excluded in
the next analysis. When cases of acute viral pneumonia
were used as a reference, the odds ratio (OR) for the in-
cidence of HCMV infection in unresolved pneumonia
cases was 2.527 and the 95% confidence interval (CI)
was 1.103–5.789 (P = 0.03). The OR for the incidence of
Table 1 Acute and unresolved pediatric pneumonia and anatomy classification of different pneumonia with
HCMV infection
Diagnosis Acute pneumonia (%) Unresolved pneumonia (%) Odds ratio P value
Non-HCMV-infection (%)a 219 (95.6) 10 (4.4) 1.00
HCMV-infection (%) 130 (89.7) 15 (10.3) 2.527 (1.103,5.789) 0.0284
HCMV-concurrent-infectionb 116 (87.2) 17 (12.8) 3.209 (1.424,7.235) 0.0049
Total 465 42
aRespiratory infection caused by other viruses but no bacterial infection.
bRespiratory infection caused by HCMV and other viruses but no bacterial infection.
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multiple viral infection was 3.209 and the 95% CI was
1.424–7.235 (P = 0.005). These findings indicated a high
percentage of HCMV infection in patients with unre-
solved pneumonia. For anatomical classification of pneu-
monia with acute HCMV infection, the percentage of
interstitial pneumonia and bronchiolitis cases with acute
HCMV infection was high, similar to a previous report
(Table 2) [23].
Clinical characteristics and WBC counts of pneumonia
patients with acute HCMV infection
Because clinical symptoms, such as a cough, sore throat,
and fever, were helpful for diagnosing pneumonia, we
screened these symptoms to help diagnose viral pneumonia
with acute HCMV infection. The probability of occurrence
of clinical symptoms, including cough, wheezing, sore
throat, and dyspnea, was significantly related to HCMV in-
fection (Table 3, P < 0.05). However, there were no signifi-
cant differences in clinical symptoms, such as fever, rodding
respiration, and three depressions sign of inspiration, and
nasal ale flap among these three groups (P > 0.05). More-
over, most children with pneumonia appeared to have a
cough, sore throat, and dyspnea. Based on our data and
a previous report [24], these symptoms are not specific
enough to distinguish pneumonia with acute HCMV in-
fection from other types of pneumonia.
The vital signs of the enrolled pneumonia patients did
not appear to be significantly different among the three
groups (P > 0.05, Additional file 1: Table S7). Therefore,
diagnosis of HCMV pneumonia by only depending on the
initial clinical symptoms and vital signs is insufficient.
Laboratory tests are helpful for diagnosing infectious
diseases. Patients with respiratory infection are usually
detected by performing a WBC count to evaluate the infec-
tion. We found that the leukocyte count and proportion of
lymphocytes were higher, while the proportion of neutro-
phils was lower in the HCMV-infection group compared
with those in the non-HCMV-infection group (P < 0.05).
However, the proportion of lymphocytes and neutrophils
in patients with acute HCMV infection were in the normal
Table 2 Anatomy classification of different pneumonia with HCMV infection
Pneumonia subtype Total Non-HCMV-Infection (%) HCMV-Inf-ection (%) HCMV-Concu-rrent-Infection Odds ratio P value
Lobar pneumonia* 80 47 (58.75) 14 (17.5) 19 (23.75) 1.00
Bronchopneu-monitis 220 106 (48.18) 81 (36.82) 33 (15.00) 1.177 (0.72,1.926) 0.5158
Interstitial pneumonia 99 37 (37.37) 31 (31.31) 31 (31.31) 2.083 (1.191,3.642) 0.0101
Bronchiolitis 110 40 (36.36) 19 (17.27) 51 (46.36) 3.045 (1.757,5.275) <.0001
*The Lobar Pneumonia group was defined as a reference.











Cough 144 (99.31) 213 (92.61) 133 (99.25) 490 (96.27) 0.0004**
Wheezing 43 (29.66) 84 (36.52) 74 (55.22) 201 (39.49) <.0001**
Sore throat 117 (80.69) 161 (70) 115 (85.82) 393 (77.21) 0.0012**
Dyspnea 75 (51.72) 140 (60.87) 93 (69.40) 308 (60.51) 0.0104*
Rodding respiration 3 (2.07) 9 (3.91) 9 (6.72) 21 (4.13) 0.1458
Three depressions sign of inspiration 20 (13.79) 38 (16.52) 29 (21.64) 87 (17.09) 0.2097
Nasal ale flap 4 (2.76) 11 (4.78) 7 (5.22) 22 (4.32) 0.5383
Fever (>37.5°C) 21 (14.48) 15 (6.52) 11 (8.21) 47 (9.23) 0.0309
WBC
WBC (×109/L) 12.29 ± 5.33 11.18 ± 4.95 10.87 ± 3.85 0.0296*
Lymphocytes% 59.92 ± 18.14 58.04 ± 18.34 65.07 ± 13.93 0.0009**
Neutrophils% 34.11 ± 18.59 35.84 ± 18.8 29.50 ± 14.14 0.0042**
Monocytes% 3.61 ± 1.99 3.73 ± 2.12 3.53 ± 1.49 0.6178
Eosinophils% 2.86 ± 2.39 2.97 ± 2.44 2.71 ± 2.28 0.6037
aRespiratory infection caused by other viruses but no bacterial infection.
bRespiratory infection caused by HCMV and other viruses but no bacterial infection.
*P < 0.05, **P < 0.01.
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range (lymphocytes, 50–70%; neutrophils, 20–40%). More-
over, although minor variations were observed in the pro-
portion of monocytes and eosinophils between children
with acute HCMV infection and those with other viral in-
fections, there was no significant difference among the
groups (P > 0.05), (Table 3).
Serological detection of IgM and detection of HCMV DNA
by real-time PCR in pneumonia patients with acute
HCMV infection
Recently, serological detection for IgM and real-time PCR
for DNA have been widely used to help diagnosis of
HCMV infection [25]. We retrospectively analyzed the re-
sults of real-time PCR and IgM assays from children with
viral pneumonia. The final clinical diagnosis was set as the
standard to test the accuracy of serological detection and
real-time PCR [16]. The accuracy of IgM results for all of
the patients was 67.78%, and it was 71.80% in the age group
of <6 months and 48.28% in the age group of >6 months.
The accuracy of real-time PCR for all of the patients was
82.32%, and it was 83.41% in the age group of <6 months
and 77.01% in the age group of >6 months. These results
showed that the accuracy of the real-time PCR assay was
higher than that of the IgM assay, and the accuracy of real-
time PCR was more stable in different age groups. These
data suggest that real-time PCR is the preferred method to
IgM serological assay for diagnosis of acute HCMV infec-
tion (Table 4).
Correlation between urinary and respiratory specimens in
pneumonia patients with acute HCMV infection
Urine is an easy specimen to obtain and is non-invasive
for infants. For detection of HCMV infection, HCMV is
known to be shed in various secretions, especially urine
[26]. In the current study, urine, blood, and respiratory
specimens from 30 children with pneumonia were col-
lected. The four main genes (pp65, pp71, pp150, and pp28),
which code tegument proteins and play an important role
in HCMV-invading host cells, were chosen for investiga-
tion. Detection of HCMV DNA and the tegument genes
by real-time PCR was performed. Only pp65 was se-
lected as the target because the other tegument genes
were not suitable for helping with diagnosis of HCMV
infection (Additional file 1: Table S8). Although the accur-
acy of real-time PCR in urine was high (Table 4), we further
considered whether urine was able to reflect acute pul-
monary infection. To test this possibility, we prospectively
selected 186 suspected pneumonia patients (18 HCMV-
pneumonia patients, 24 with acute HCMV infection, 123
with latent HCMV infection, and 21 with non-HCMV in-
fection), and simultaneously collected urinary and respira-
tory specimens (sputum or BALF) from each patient. The
individual data of the 186 suspected pneumonia patients
are shown in Additional file 1: Table S9. The HCMV
DNA copy numbers of these two types of samples were
then detected by real-time PCR. As shown in Table 5, the
copy numbers of HCMV DNA were correlated with each
other. There was no significant difference in HCMV DNA
copy number between urinary and respiratory specimens
for each patient, suggesting that urine is a suitable sample
for pediatric acute pulmonary HCMV infection.
Diagnosis of acute HCMV infection in clinical specimens
of child pneumonia
In our study, the false positive and negative rates of real-
time PCR for detecting the copy number of HCMV DNA
were 21.0% (48/229) and 14.7% (41/279), respectively, in
509 retrospective cases (Additional file 1: Table S10). We
further aimed to identify a more specific and sensitive
marker for acute HCMV infection. Because pp65 is an













All 279 230 190 (68.10) 155 (67.39) 238 (85.30) 181 (78.70)
<6 m 232 190 164 (70.69) 139 (73.16) 197 (84.91) 155 (81.58)
>6 m 47 40 26 (55.32) 16 (40.00) 41 (87.23) 26 (65.00)
Total 509 345 (67.78) 419 (82.32)
Table 5 The correlation of HCMV DNA with urine and respiratory specimen
Urine/respiratory specimen χ2 P
value+/+ -/+ +/- -/-
HCMV-pneumonia 18 (100) 0 0 0 - -
Virus pneumonia with acute HCMV infection 18 (75) 6 (25) 0 0 - -
HCMV-latent-infection 39 (31.7) 3 (2.4) 6 (4.9) 75 (61.0) 1.00 0.3173
Non-HCMV-infection 6 (28.6) 3 (14.3) 0 12 (57.1) 3.00 0.0833
Total 81 (43.5) 12 (6.5) 6 (3.2) 87 (46.8) 2.00 0.1573
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important gene for reflecting acute HCMV infection
[10,11], we then used real-time PCR to measure the pp65
gene in urine of children with pneumonia. There was no
significant difference in pp65 gene expression between
urinary and respiratory specimens (Table 6). Interestingly,
the false positive and negative rates of the pp65 gene were
only 6.9% (10/144) and 7.1% (3/42), respectively, in these
patients (Table 7). This finding indicated that pp65 was
much more accurate than HCMV DNA for detecting acute
HCMV infection in children with pneumonia. However,
we could not identify the ideal receiver operating charac-
teristic curve and analysis by only using the pp65 gene
from current data (Figure 1).
Discussion
For pneumonia, it is difficult to establish a “gold stand-
ard” to identify acute HCMV infection. In our study, the
criteria for diagnosis of HCMV pneumonia were a posi-
tive HCMV IgM or a positive real-time PCR result for
HCMV DNA, and exclusion of all bacterial, MP, and other
viral infections. In our retrospective study, the incidence
of HCMV pneumonia was 6.59% (145/2201) in children
with pneumonia in the southwest part of China.
In our study, although the odds ratio of HCMV infec-
tion in males was slightly higher than that in females,
there was no significant difference. Similar results of
no significant differences in age and duration of illness
were found among the different HCMV infection groups
(Additional file 1: Tables S4–S5). Moreover, pediatric inter-
stitial pneumonia and bronchiolitis were associated with
a higher percentage of HCMV infection, consistent with
recent reports [21].
We also demonstrated that the probability of occurrence
of a cough, wheezing, sore throat, and dyspnea was differ-
ent in pneumonia patients with or without acute HCMV
infection. However, the differences in the rate of coughing
and a sore throat among these groups were not significant
enough to distinguish HCMV infection alone from mul-
tiple viral infections. Interestingly, the rate of wheezing
and dyspnea was lowest in HCMV infection alone and
highest with multiple viral infections. We speculate that
HCMV infection does not cause wheezing and dyspnea as
frequently as RSV or other viral infections. HCMV infec-
tion could alter the immune system in infants, and destroy
the natural killer activity to some extent. This makes in-
fants more vulnerable to RSV and other viruses, causing
wheezing and dyspnea [27].
With regard to WBC count in our study, the proportion
of lymphocytes and neutrophils in patients with acute
HCMV infection was in the normal range. The results of
initial clinical symptoms, vital signs, and WBCs were not
specific. Therefore, new laboratory assays for determining
acute HCMV infection need to be developed.
Currently, there are several types of etiological tests to
detect HCMV infection. Isolation and culture of HCMV
is the most specific method, but is time consuming and
has low sensitivity. This method is also not suitable for
routine diagnosis [4,5]. In most laboratories, serological
tests are used as standard diagnostic methods. Our study
showed that the accuracy of real-time PCR for HCMV
Table 6 The correlation of pp65 between urine and respiratory specimen
Urine/respiratory specimen (%) χ2 P value
+/+ -/+ +/- -/-
HCMV-pneumonia 18 (100) 0 0 0 - -
Virus pneumonia with acute HCMV infection 21 (87.5) 0 0 3 (12.5) - -
HCMV-latent-infection 3 (2.4) 2 (1.6) 4 (3.3) 114 (92.7) 0.67 0.4142
Non-HCMV-infection 1 (4.8) 0 2 (9.5) 18 (85.7) 2.00 0.1573
Total 43 (23.1) 2 (1.1) 6 (3.2) 135 (72.6) 2.00 0.1573
Table 7 The correlation of pp65 with clinical diagnosis in
different age
PP65/clinical diagnosis (%) χ2 P value
+/+ -/+ +/- -/-
<6 m 30 (22.7) 3 (2.3) 7 (5.3) 92 (69.7) 1.60 0.2059
>6 m 9 (16.7) 0 3 (5.6) 42 (77.8) 3.00 0.0833
Total 39 (21.0) 3 (1.6) 10 (5.4) 134 (72.0) 3.77 0.0522
Figure 1 ROC analysis of pp65 gene detection between HCMV-
Acute-Infection and HCMV-Latent-Infection.
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DNA was higher than that of the IgM assay. The results
of real-time PCR for detecting HCMV DNA were more
stable in different age groups. IgM results are not reli-
able in children because of the immature immunological
response, especially in children aged <6 months, who are
the main population for acute HCMV infection [20]. There-
fore, real-time PCR was superior to serology for diagnosis
of HCMV infection in children younger than 6 months old.
Detection of HCMV DNA and the tegument genes
(pp65, pp71, pp150, and pp28) by real-time PCR was per-
formed. The positive rates of variables measured in per-
ipheral blood in all of the methods were too low to help
diagnose acute pulmonary HCMV infection (Additional
file 1: Table S8). Moreover, peripheral blood is a difficult
specimen to obtain and is invasive for children, especially
for those aged <6 months. A peripheral blood specimen
is not suitable for measuring infection in children. In
addition, the positive rates of pp71, pp150, and pp28 were
too low to help diagnose HCMV infection when urinary
and respiratory specimens were examined (Additional
file 1: Table S8). Therefore, only pp65 was selected as
the target. In addition, there was no significant difference
in detecting HCMV DNA and the pp65 gene by real-time
PCR between urinary and respiratory specimens. This find-
ing indicates that urine is a suitable specimen for diagnosis
of pulmonary HCMV infection, suggesting that urine could
replace respiratory specimens. Taking a urine sample is
non-invasive and easy to obtain, and could be used to diag-
nose pulmonary HCMV infection in infants with classic
pneumonia symptoms.
HCMV carriers usually had positive HCMV DNA by
real-time PCR in our study. However, this was result not
sufficient for diagnosing acute pulmonary HCMV infec-
tion. Although the accuracy of real-time PCR for the
pp65 gene was much better than that for HCMV DNA,
pp65 gene expression alone could not be used to distin-
guish acute HCMV infection from latent infection. We
attempted to establish a standard to distinguish acute
HCMV infection from latent infection via real-time PCR
for the pp65 gene. However, we could not identify the
ideal receiver operating characteristic curve and analysis
by only using the pp65 gene from current data (Figure 1).
Optimized reaction methods for the pp65 gene need to
be further studied.
Conclusions
In summary, we provide a better understanding on the in-
cidence, and clinical and laboratory characteristics of acute
HCMV infection in pediatric pneumonia. Real-time PCR is
more accurate and stable than serological IgM assay for
detecting acute pulmonary HCMV infection in children.
More importantly, urine is a suitable sample for determin-
ing pulmonary HCMV infection in children. This indicates
the potential use of this non-invasive and easy-to-obtain
specimen for diagnosis of HCMV infection in pulmonary
diseases. Although the pp65 gene is a candidate marker for
acute HCMV infection, the specificity and sensitivity of
real-time PCR should be further optimized, and the pp65
gene should be combined with other potential markers.
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